SIGA Technologies (SIGA) Stock Price, News & Analysis

Company Overview

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Key Stats

• Today's Range: $6.17 to $6.39
• 50-Day Range: $5.73 to $7.36
• 52-Week Range: $4.26 to $12.83
• Volume: 306,814 shs
• Average Volume: 388,384 shs
• Market Capitalization: $451.25 million
• P/E Ratio: 5.27
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SIGA Technologies Stock Analysis - MarketRank™

SIGA Technologies scored higher than 34% of companies evaluated by MarketBeat, and ranked 785th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for SIGA Technologies.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 20.19%

Earnings Growth

Earnings for SIGA Technologies are expected to grow by 20.19% in the coming year, from $1.04 to $1.25 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of SIGA Technologies is 5.27, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.70.

Price to Earnings Ratio vs. Sector

The P/E ratio of SIGA Technologies is 5.27, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.58.

Price to Book Value per Share Ratio

SIGA Technologies has a P/B Ratio of 2.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.61% of the float of SIGA Technologies has been sold short.

Short Interest Ratio / Days to Cover

SIGA Technologies has a short interest ratio ("days to cover") of 7.1.

Change versus previous month

Short interest in SIGA Technologies has recently decreased by 0.85%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SIGA Technologies does not currently pay a dividend.

Dividend Growth

SIGA Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

8.61% of the float of SIGA Technologies has been sold short.

Short Interest Ratio / Days to Cover

SIGA Technologies has a short interest ratio ("days to cover") of 7.1.

Change versus previous month

Short interest in SIGA Technologies has recently decreased by 0.85%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: N/A

News Sentiment

SIGA Technologies has a news sentiment score of -0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.

Search Interest

7 people have searched for SIGA on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SIGA Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.54% of the stock of SIGA Technologies is held by insiders.

Percentage Held by Institutions

55.40% of the stock of SIGA Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SIGA Stock Analysis - Frequently Asked Questions

How have SIGA shares performed this year?

SIGA Technologies' stock was trading at $6.01 at the start of the year. Since then, SIGA shares have increased by 5.2% and is now trading at $6.3250.
View the best growth stocks for 2025 here.

How were SIGA Technologies' earnings last quarter?

SIGA Technologies, Inc. (NASDAQ:SIGA) announced its quarterly earnings results on Thursday, November, 7th. The company reported $0.02 EPS for the quarter. The firm earned $10.01 million during the quarter. SIGA Technologies had a trailing twelve-month return on equity of 49.06% and a net margin of 49.33%.

Who are SIGA Technologies' major shareholders?

SIGA Technologies' top institutional investors include Harbor Capital Advisors Inc. (0.24%), Exchange Traded Concepts LLC (0.07%), Linden Thomas Advisory Services LLC (0.03%) and SG Americas Securities LLC (0.03%).
View institutional ownership trends.

How do I buy shares of SIGA Technologies?

Shares of SIGA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SIGA Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SIGA Technologies investors own include Voyager Therapeutics (VYGR), American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 1/21/2025
• Next Earnings (Estimated): 3/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SIGA
• CUSIP: N/A
• CIK: 1010086
• Web: www.siga.com
• Phone: (212) 672-9100
• Fax: 212-697-3130
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $1.20
• Trailing P/E Ratio: 5.26
• Forward P/E Ratio: 6.07
• P/E Growth: N/A
• Net Income: $68.07 million
• Net Margins: 49.33%
• Pretax Margin: 63.52%
• Return on Equity: 49.06%
• Return on Assets: 38.72%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.10
• Quick Ratio: 5.32

Sales & Book Value

• Annual Sales: $139.92 million
• Price / Sales: 3.22
• Cash Flow: $0.98 per share
• Price / Cash Flow: 6.45
• Book Value: $2.77 per share
• Price / Book: 2.28

Miscellaneous

• Outstanding Shares: 71,400,000
• Free Float: 70,305,000
• Market Cap: $450.53 million
• Optionable: Optionable
• Beta: 0.94